Join
Live feed
·
PRReleasevia Quantisnow
bluebird bio Inc. logo
The Carlyle Group Inc. logo

Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLUE (bluebird bio Inc.), CG (The Carlyle Group Inc.) and more on Quantisnow.